Codexis (CDXS) Return on Invested Capital (2019 - 2020)

Codexis' (CDXS) quarterly Return on Invested Capital came in at 6.22% in Q4 2020, down 600.0% year-on-year from 1.24% in Q1 2020, and down 279.9% quarter-over-quarter from 1.64% in Q3 2020.

Codexis (CDXS) Return on Invested Capital (2019 - 2020) Analysis & Trends

Codexis' Return on Invested Capital history runs 2 years deep, the most recent figure standing at 6.22% for Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.00%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.04%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Codexis 180.63 Mn 115.49 Mn 13.18 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2020 -6.22%
Sep 30, 2020 -1.64%
Jun 30, 2020 -0.53%
Mar 31, 2020 -0.31%
Dec 31, 2019 -0.22%
Sep 30, 2019 -0.25%
Jun 30, 2019 -0.44%